bluuebunny/crossref_metadata_2025_split huggingface dataset:
The influence of different therapists on functional analysis outcomes
Authors: McAdam David B. , DiCesare Anthony , Murphy Sean , Marshall Bernard 
Published: January 2004

AbstractRecently, researchers have demonstrated that certain antecedent variables can affect the results of a functional analysis. The purpose of the current study was to evaluate the effects of family members versus a direct‐care staff member on the occurrence of problem behaviors during three concurrently conducted functional analyses. The results of the functional analyses demonstrated that the participant's problem behaviors were maintained by positive reinforcement (i.e. access to tangible items) and negative reinforcement (i.e. escape from demands) when either his mother or stepfather was the therapist in the functional analysis; however, no problem behaviors were displayed when a direct‐care staff member was the therapist in the functional analysis. Copyright © 2004 John Wiley & Sons, Ltd.
Toilet training for a young boy with pervasive developmental disorder
Authors: Post A. Randi , Kirkpatrick Michael A. 
Published: January 2004

AbstractWe employed a variation of the Azrin–Foxx (1971) procedure with a 3.5‐year‐old boy diagnosed with Pervasive Developmental Disability (PDD). Unique features of our design included tailoring to the in‐home environment, training without systematically increasing fluid intake, introduction under circumstances that facilitated generalization and transfer without special procedures, the elimination of some specialized equipment, and use of social and activity reinforcers. Training was successful and was reported to have generalized to the inclusive school environment. Copyright © 2004 John Wiley & Sons, Ltd.
Determining the influence of tangible items on screaming and handmouthing following an inconclusive functional analysis
Authors: Carter Stacy L. , Devlin Sandy , Doggett R. Anthony , Harber Melissa M. , Barr Candice 
Published: January 2004

AbstractA brief experimental analysis was used to compare the effects of the presence of tangible objects in an alone condition following an inconclusive functional analysis of screaming and handmouthing behavior of an 8‐year‐old boy. The alone condition with tangibles involved having toys available throughout the session with no interaction from the therapist and produced a higher percentage of intervals with screaming and handmouthing. The study demonstrates the importance of evaluating the effects of the presence of tangible items during a functional analysis. Copyright © 2004 John Wiley & Sons, Ltd.
Kissing sirolimus‐eluting stents for the treatment of left main coronary artery stenosis
Authors: Cox Nicholas , Rogers Campbell 
Published: January 2004

AbstractWe present a case of kissing drug‐eluting stent deployment in the left main coronary artery in a 43‐year‐old male with failed previous bypass grafting. We discuss the technique used for stent deployment and the rationale for using this technique in the drug‐eluting stent era. Catheter Cardiovasc Interv 2004;61:206–210. © 2004 Wiley‐Liss, Inc.
Long‐term follow‐up of brachytherapy for treatment of allograft in‐stent restenosis
Authors: Zoghbi Gilbert J. , Misra Vijay K. , Chapman Gregory D. , Hillegass William B. , Brott Brigitta C. , Aqel Raed A. , Bourge Robert C. 
Published: January 2004

AbstractThe experience of brachytherapy in the treatment of in‐stent restenosis of allograft arteries is limited. We present two cases of in‐stent restenosis treated with brachytherapy with favorable angiographic follow‐up at 10 months in one patient and at 17 months in the other. Catheter Cardiovasc Interv 2004;61:217–221. © 2004 Wiley‐Liss, Inc.
Ulnar artery catheterization with occlusion of corresponding radial artery
Authors: Lanspa Thomas J. , Reyes Antonio P. , Oldemeyer J. Bradley , Williams Mark A. 
Published: January 2004

AbstractThe transradial approach to coronary angiography has become a popular technique. Because of potential advantages, the transulnar approach has also recently been described. We report a successful case of transulnar catheterization with documented occlusion of the radial artery and normal inverse Allen test in a patient with limited vascular access. Catheter Cardiovasc Interv 2004;61:211–213. © 2004 Wiley‐Liss, Inc.
Reliable anticoagulation with enoxaparin in patients undergoing percutaneous coronary intervention: The pharmacokinetics of enoxaparin in PCI (PEPCI) study
Authors: Martin Jack L. , Fry Edward T.A. , Sanderink Ger‐Jan C.M. , Atherley Trevor H. , Guimart Colette M. , Chevalier Paul J. , Ozoux Marie‐Laure , Pensyl Catherine E. , Bigonzi Frederique 
Published: January 2004

AbstractThe objective of this study was to evaluate the pharmacokinetic response to intravenous (IV) enoxaparin given 8–12 hr after subcutaneous (SC) dosing in patients undergoing percutaneous coronary intervention (PCI). Fifty‐five patients received SC enoxaparin (1 mg/kg every 12 hr) followed by an IV bolus (0.3 mg/kg) 8–12 hr after the last SC dose, at the start of PCI or during catheterization. Anti‐Xa levels were within the target range in 98% of patients 2–8 hr after the last SC dose, in 96% of patients following the IV bolus, and in 91% of patients for a further 2 hr. Subcutaneous enoxaparin (1 mg/kg every 12 hr) provides sufficient anti‐Xa levels for PCI 2–8 hr after the last dose. An additional 0.3 mg/kg enoxaparin dose given IV 8–12 hr after the last SC dose reliably maintains anti‐Xa levels within the target for at least 2 additional hr. Catheter Cardiovasc Interv 2004;61:163–170. © 2004 Wiley‐Liss, Inc.
Safety of a high bolus dose of tirofiban in patients undergoing coronary stent placement
Authors: Danzi Gian B. , Capuano Cinzia , Sesana Marco , Baglini Roberto 
Published: January 2004

AbstractTo overcome the suboptimal platelet inhibition induced by tirofiban in the first hour after a percutaneous coronary intervention, a new regimen of 25 μg/kg bolus followed by an 18‐hr infusion of 0.15 μg/kg/min has been proposed. The aim of this study was to compare the effects of this high bolus dose of tirofiban with those of abciximab on bleeding risk and 30‐day clinical outcome in patients undergoing coronary stenting. We compared two cohorts of patients who underwent coronary stent placement between January 2000 and December 2002. In the first cohort, the only available IIb/IIIa receptor inhibitor was abciximab, which was given to 280 (34.9%) out of 802 stented patients; in the second cohort, tirofiban was administered to 274 (38.3%) out of 716 treated patients. The primary endpoints were the proportion of patients with major bleeding and the rate of site access complications; the 30‐day incidence of major adverse cardiac events (MACE) was also assessed. After the procedure, the patients were given ticlopidine for 4 weeks and aspirin indefinitely. Major bleeding episodes were observed in four patients receiving abciximab and in none receiving tirofiban (1.4% vs. 0%; P = 0.12); the rates of site access complications were similar (3.6% vs. 3.3%; P = 0.96). The 30‐day incidence of MACE was 7.1% in the abciximab group and 5.8% in the tirofiban group (P = 0.65). In patients undergoing coronary stenting, the high bolus dose of tirofiban is safe and not associated with an increased risk of major bleeding or site access complications in comparison with abciximab. Catheter Cardiovasc Interv 2004;61:179–184. © 2004 Wiley‐Liss, Inc.
Relationship between pattern of slow‐reflow and tissue level of perfusion after coronary stenting: A single‐patient report
Authors: Ramondo Angelo , Tarantini Giuseppe , Napodano Massimo , Bilato Claudio , Cacciavillani Luisa , Iliceto Sabino 
Published: January 2004

AbstractThs study reports different mechanisms (i.e., microvascular spasm and discrete microinfarction) that may underlie different pattern of slow‐reflow after elective coronary stenting on the basis of the different tissue level of perfusion achieved, assessed by blush grade and MRI. Catheter Cardiovasc Interv 2004;61:222–226. © 2004 Wiley‐Liss, Inc.
Endovascular stent implantation for severe pulmonary artery stenosis in aortoarteritis (Takayasu's arteritis)
Authors: Tyagi Sanjay , Mehta Vimal , Kashyap Ravi , Kaul Upkar A. 
Published: January 2004

AbstractSymptomatic pulmonary artery stenosis is a relatively uncommon manifestation of aortoarteritis. We describe a patient of aortoarteritis with severe proximal right pulmonary artery stenosis who presented with dyspnea on exertion and central cyanosis. The pulmonary artery stenosis was successfully relieved by percutaneous transluminal balloon angioplasty and implantation of a balloon‐expandable stent. This resulted in immediate improvement in oxygen saturation, disappearance of cyanosis, relief of dyspnea, and marked improvement in right lung perfusion as demonstrated by pre‐ and postangioplasty technetium lung ventilation‐perfusion scans. The changes in the pulmonary arterial wall morphology were detected precisely by intravascular ultrasound imaging. Catheter Cardiovasc Interv 2004;61:281–285. © 2004 Wiley‐Liss, Inc.
A “mouse in a trap” method for cerebral protection during carotid stenting: Technical note
Authors: Nishi Shogo , Katsuki Takahisa , Mori Hisae , Ohwaki Hisayuki , Iwasaki Kohichi 
Published: January 2004

AbstractCarotid artery angioplasty and stenting (CAS) is now used as an alternative to surgical endarterectomy. The introduction of cerebral protection systems during stenting has improved carotid artery stenosis treatment, with less periprocedural complications. A “mouse in a trap” method was conceived and used in three patients. This involved an emboli entrapment‐aspiration system using one proximal occluder in the common carotid artery and two distal occluders in the internal carotid artery or external carotid artery, followed by serial inflation‐deflation cycles during each carotid stenting procedure. Debris was retrieved before dilation in one patient, after deployment in one, and after dilation in two. Although only used in a few cases to date, the method may improve the practice of CAS in treating patients with carotid stenosis, resulting in less thromboembolic events. Catheter Cardiovasc Interv 2004;61:275–280. © 2004 Wiley‐Liss, Inc.
Stent implantation in right‐sided patent ductus arteriosus to relieve severe cyanosis in adult patient with pulmonary atresia and ventricular septal defect
Authors: Tyagi Sanjay , Dwivedi Girish , Gupta Mohit Dayal , Kaul Upkar A. 
Published: January 2004

AbstractPatients with unrepaired pulmonary atresia and ventricular septal defect may develop stenosis of collaterals or shunts to the pulmonary arteries leading to hypoperfusion of lungs and systemic hypoxemia. A 25‐year‐old female with pulmonary atresia and ventricular septal defect presented with progressively increasing cyanosis and exercise intolerance. A restrictive right‐sided patent ductus arteriosus was identified as the main source of pulmonary blood flow. We report transcatheter implantation of a balloon‐expandable stent across the stenosed duct to augment the pulmonary blood flow as a palliative management option. Patient had immediate improvement in arterial oxygen saturation from 66% to 85% with excellent clinical improvement and stable oxygen saturation on 8 months of follow‐up. Catheter Cardiovasc Interv 2004;61:271–274. © 2004 Wiley‐Liss, Inc.
Native right ventricular outflow stent implantation in patients with unsalvageable extracardiac conduits
Authors: Veldtman Gruschen R. , Sugiyama Hisashi , Norgard Gunnar , Mikailian Haverj , Lee Kyong‐Jin , Benson Lee N. 
Published: January 2004

AbstractWe describe two patients with unsalvageable ventricular‐to‐pulmonary artery conduits in whom endovascular stents were implanted in the native right ventricular (RV) outflow providing double outlet ventricle and RV hypertension relief. Both patients are free from surgical reintervention at 7 years and 5 months, respectively. Catheter Cardiovasc Interv 2004;61:256–258. © 2004 Wiley‐Liss, Inc.
Transcatheter closure of double atrial septal defects with a single Amplatzer device
Authors: Szkutnik Malgorzata , Masura Jozef , Bialkowski Jacek , Gavora Pavol , Banaszak Pawel , Kusa Jacek , Zembala Marian 
Published: January 2004

AbstractTranscatheter closure of single secundum atrial defects has become the standard of treatment. The purpose of our study was to analyze the results of using a single Amplatzer device for closure of double atrial septal defects. Such defects were diagnosed in 41 out of 363 patients with atrial septal defects (ASDs) closed by transcatheter method. In 39, a single Amplatzer device was used. The size of the larger defect ranged from 5 to 18 mm, the smaller defect from 2 to 7 mm, with the distance between the borders of the communications ranging from 2 to 12 mm. We performed sizing and closure of only the larger defect. The mean size of implanted devices was 16.5 ± 5.5 mm, equal to the stretched diameter of the main defect or 1–4 mm larger. The closure rate assessed by color Doppler flow examination was 61% after 24 hr, 78% after 1 month, 83% after 3 months, 86% after 1 year, and 95% after 2 years. If the distance between the two defects exceeded 7 mm, residual leaks were observed but tended to decrease and disappear with time. Selected patients with double atrial septal defects can be effectively treated with implantation of a single Amplatzer device. Catheter Cardiovasc Interv 2004;61:237–241. © 2004 Wiley‐Liss, Inc.
New strategies in the percutaneous management of coronary artery fistulae: A case report
Authors: Goldberg Steven L. , Makkar Raj , Duckwiler Gary 
Published: January 2004

AbstractCoronary artery fistulae are rare anomalies often treated percutaneously. New techniques aiding in the percutaneous closure of a giant coronary artery, not previously described, are presented in a case report. These techniques include the use of intravascular ultrasound imaging and the use of electrolytically detachable platinum coils. Catheter Cardiovasc Interv 2004;61:227–232. © 2004 Wiley‐Liss, Inc.
Rheolytic thrombectomy with distal filter embolic protection as adjunctive therapies to high‐risk saphenous vein graft intervention
Authors: Ho Paul C. , Leung Cyril Y. 
Published: January 2004

AbstractPercutaneous intervention of saphenous vein graft (SVG), especially those with heavy atherothrombotic load, presents high risk for distal embolization and no‐reflow. Using the distal filters alone may occasionally be disadvantageous because of the large debris burden and the inability to assess the underlying culprit lesions and vessel size accurately. We present a case of intervention of an occluded SVG using a combination of rheolytic thrombectomy and distal filter embolic protection as a pretreatment before stenting. This strategy has the potential to reduce further the risk of no‐reflow and to provide visualization for proper assessment of the underlying anatomy especially in clot‐laden vessels. Catheter Cardiovasc Interv 2004;61:202–205. © 2004 Wiley‐Liss, Inc.
Reactivity of the ductus arteriosus: Implications for transcatheter therapy
Authors: Lozier John S. , Cowley Collin G. 
Published: January 2004

AbstractWe report our experience in a 13‐month‐old boy undergoing transcatheter coil occlusion of a patent ductus arteriosus. Constriction of the ductus arteriosus with subsequent relaxation resulted in inadvertent coil embolization. This case report and review of the literature have implications for transcatheter treatment of persistent ductus arteriosus. Catheter Cardiovasc Interv 2004;61:268–270. © 2004 Wiley‐Liss, Inc.
Retrograde wire‐assisted percutaneous transcatheter closure of persistent ductus arteriosus with Amplatzer duct occluder in the elderly: A new application
Authors: Hsin Ho‐Tsung , Lin Lung‐Chun , Hwang Juey‐Jen , Ho Shinn‐Ge , Tseng Chuen‐Den , Chiang Fu‐Tein 
Published: January 2004

AbstractPercutaneous transcatheter closure of persistent ductus arteriosus (PDA) has been well established in the pediatric field. For moderate‐ to large‐sized PDA, the newly developed Amplatzer duct occluder had offered a good solution, but it depends on stiff wire and delivery sheath. We reported two elderly patients of PDA with vascular anatomy too difficult to be antegradely approached and were closed by a retrograde technique by an assisting wire from the descending aorta. The wire served as a guide and tracked the delivery system to cross the ductus from the venous side smoothly. This retrograde wire‐assisted technique could be utilized to overcome the PDA of difficult vascular anatomy, which could not be easily fulfilled by conventional antegrade venous approach. Catheter Cardiovasc Interv 2004;61:264–267. © 2004 Wiley‐Liss, Inc.
GP IIb/IIIa inhibition with eptifibatide lowers levels of soluble CD40L and RANTES after percutaneous coronary intervention
Authors: Welt Frederick G.P. , Rogers Sarah D. , Zhang Xiaobin , Ehlers Raila , Chen Zhiping , Nannizzi‐Alaimo Lisa , Phillips David R. , Simon Daniel I. 
Published: January 2004

AbstractPlatelets are the most abundant blood source of CD40L, a proinflammatory and prothrombotic costimulatory molecule implicated in atherosclerosis. Agonist stimulation results in the secretion of a soluble form of CD40L (sCD40L) and GP IIb/IIIa receptor inhibition blocks secretion of sCD40L in vitro. However, the effect of GP IIb/IIIa inhibition on sCD40L levels in humans is unknown. Plasma sCD40L and inflammatory markers were measured (t = 0, 0.5, 2, and 24 hr post‐PCI) in a cohort of patients receiving abciximab (n = 15), eptifibatide (n = 15), or no GP IIb/IIIa inhibitor (n = 15). PCI in the absence of GP IIb/IIIa inhibitor was associated with a small but measurable rise in sCD40L and the platelet‐derived chemokine RANTES. In contrast, eptifibatide significantly lowered baseline sCD40L (P = 0.018) and RANTES (P = 0.006) levels. This effect was not observed with abciximab. GP IIb/IIIa inhibition with eptifibatide lowers levels of sCD40L and RANTES post‐stenting, possibly conferring anti‐inflammatory as well as antithrombotic effects. Catheter Cardiovasc Interv 2004;61:185–189. © 2004 Wiley‐Liss, Inc.
Stent implantation in the ductus arteriosus for pulmonary blood supply in congenital heart disease
Authors: Michel‐Behnke Ina , Akintuerk Hakan , Thul Josef , Bauer Juergen , Hagel Karl‐Juergen , Schranz Dietmar 
Published: January 2004

AbstractIndications for catheter‐based interventions in patent ductus arteriosus (PDA)‐dependent pulmonary blood flow have yet to be defined. The aim of this study was to assess the acute and midterm outcome after stent implantation in the PDA. Between 1996 and 2002, ductal stenting was performed in 21 neonates and infants (14 females/7 males) to maintain pulmonary blood supply in cyanotic congenital heart disease (CHD). Balloon‐expandable stents were implanted in the PDA with a final diameter of 4–5 mm without procedural deaths. Stent patency was achieved for 8–1,130 days (median, 142). Reintervention was necessary in nine patients. Overall survival rate after 6 years was 86%. Two neonates died a few days after the procedure due to right heart failure not related to PDA stenting. Corrective surgery was possible in six patients. An additional aortopulmonary shunt was needed in three patients; Fontan type operations were performed in six. One patient died after bidirectional Glenn shunt, another five reached palliation by additional perforation of the atretic valve/balloon valvuloplasty, and two are awaiting surgery. We conclude that in many patients with cyanotic CHD, especially in those with ductal pulmonary perfusion and additional forward flow from the right ventricle, ductal stenting is an effective transcatheter approach. Morphology of the PDA predicts the risk of restenosis and necessity of reintervention. Growth of the pulmonary vascular bed allows corrective or palliative surgery, and some patients can be cured by the intervention alone. Catheter Cardiovasc Interv 2004;61:242–252. © 2004 Wiley‐Liss, Inc.
Mechanical thrombectomy using the AngioJect in a child with congenital heart disease
Authors: Vincent Robert N. , Dinkins Jeanne , Dobbs Melinda C. 
Published: January 2004

AbstractAcute thrombosis of a vascular channel can be a serious and perhaps fatal complication. We describe a patient who developed complete thrombosis of the left pulmonary artery following catheter placement of a stent in this vessel shortly after open heart surgery. The thrombosis was successfully removed using the Possis AngioJet mechanical thrombectomy catheter. Catheter Cardiovasc Interv 2004;61:253–255. © 2004 Wiley‐Liss, Inc.
Transcatheter closure of postinfarction ventricular septal defects using the new Amplatzer muscular VSD occluder: Results of a U.S. Registry
Authors: Holzer Ralf , Balzer David , Amin Zahid , Ruiz Carlos E. , Feinstein Jeffrey , Bass John , Vance Michael , Cao Qi‐Ling , Hijazi Ziyad M. 
Published: January 2004

AbstractThe objective of this study was to assess the immediate and mid‐term results of transcatheter closure of postinfarct muscular ventricular septal defects (VSDs) using the new Amplatzer postinfarct muscular VSD device (PIMVSD). Ventricular septal rupture occurs in 0.2% of myocardial infarcts and remains associated with very high morbidity and mortality. Data were prospectively collected for 18 patients who underwent attempted device closure of postinfarction VSDs between 2000 and 2003. Five patients underwent the closure in the acute phase (within 6 days from the infarct); the remaining patients underwent closure on day 14–95 after the diagnosis of the infarct. Outcome parameters included procedural success, evidence of residual shunts on echocardiography, and occurrence of procedure‐related complications. The procedure was successful in deploying a device across the VSD in 16 of 18 patients. The 30‐day mortality was 28%. Eleven patients are still alive and have been followed up for a median of 332 days. Two patients required a second procedure to close a residual VSD. At the most recent outpatient follow‐up, the VSD was completely closed in two patients, six patients had a trivial or small residual shunt, and two patients had a moderate residual shunt. We conclude that percutaneous device closure of postinfarction VSDs using the Amplatzer PIMVSD occluder appears to be safe and effective. Further trials are required to assess long‐term efficacy and compare the results with those of surgical closure. Catheter Cardiovasc Interv 2004;61:196–201. © 2004 Wiley‐Liss, Inc.
Intracoronary brachytherapy, a promising treatment option for diabetic patients: Results from a European multicenter registry (RENO)
Authors: Naber Christoph K. , Baumgart Dietrich , Bonan Raoul , Wegscheider Karl , Serruys Patrick W. , Colombo Antonio , Silber Sigmund , Eeckhout Eric , Eggebrecht Holger , Erbel Raumund , Urban Philip 
Published: January 2004

AbstractDespite advances in the interventional treatment of coronary disease, diabetics still have double the case fatality rate as nondiabetics. The purpose of this analysis from the Radiation in Europe With Novoste (RENO) registry was to assess the clinical and angiographic 6‐month outcome of diabetic patients in comparison to nondiabetic patients after localized β‐radiation. A total of 1,098 patients (83.8% with in‐stent restenosis) treated with the Novoste Beta‐Cath system in Europe were enrolled in the RENO registry. Diabetes was, irrespective of the type of lesion treated, no significant risk factor for major adverse cardiac events or target vessel revascularization. Individuals with diabetes (n = 256) and without diabetes (n = 833) displayed no significant differences concerning clinical or angiographic endpoints. Vascular brachytherapy appears to be the first technique to even out the increased risk of diabetic patients undergoing percutaneous coronary interventions in the routine clinical setting. Thus, intracoronary brachytherapy represents a promising treatment option for diabetic patients. Catheter Cardiovasc Interv 2004;61:173–178. © 2004 Wiley‐Liss, Inc.